Hot Pursuit     19-Jun-24
Glenmark Pharmaceuticals Ltd spurts 0.7%, gains for five straight sessions
Glenmark Pharmaceuticals Ltd is quoting at Rs 1251.5, up 0.7% on the day as on 12:44 IST on the NSE. The stock is up 94.38% in last one year as compared to a 25.2% gain in NIFTY and a 48.96% gain in the Nifty Pharma.

Glenmark Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting at Rs 1251.5, up 0.7% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.01% on the day, quoting at 23559.35. The Sensex is at 77463.83, up 0.21%. Glenmark Pharmaceuticals Ltd has added around 20.98% in last one month.

Meanwhile, Nifty Pharma index of which Glenmark Pharmaceuticals Ltd is a constituent, has added around 2.68% in last one month and is currently quoting at 19826.65, down 0.54% on the day. The volume in the stock stood at 5.53 lakh shares today, compared to the daily average of 13.62 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 1251.5, up 0.72% on the day. Glenmark Pharmaceuticals Ltd is up 94.38% in last one year as compared to a 25.2% gain in NIFTY and a 48.96% gain in the Nifty Pharma index.

The PE of the stock is 24.61 based on TTM earnings ending March 24.

Previous News
  Glenmark Pharmaceuticals launches TEVIMBRA® in India
 ( Corporate News - 24-Jun-25   10:53 )
  Nifty fails to hold 24,850 mark; media shares tumble
 ( Market Commentary - Mid-Session 18-Jun-25   11:36 )
  Glenmark pharma's US facility receives five observations after USFDA GMP inspection
 ( Hot Pursuit - 18-Jun-25   09:51 )
  Glenmark Pharmaceuticals Ltd soars 0.98%, rises for fifth straight session
 ( Hot Pursuit - 11-Jun-25   13:00 )
  Glenmark Pharma rises after zanubrutinib launch in India
 ( Hot Pursuit - 09-Jun-25   12:02 )
  Glenmark receives DCGI approval to launch oncology drug BRUKINSA in India
 ( Corporate News - 09-Jun-25   11:04 )
  Board of Glenmark Pharmaceuticals recommends final dividend
 ( Corporate News - 24-May-25   11:52 )
  Glenmark Pharmaceuticals reports consolidated net profit of Rs 4.65 crore in the March 2025 quarter
 ( Results - Announcements 24-May-25   07:44 )
  Glenmark Pharmaceuticals grants 1.19 lakh stock options under ESOS
 ( Corporate News - 22-May-25   16:03 )
  Glenmark Pharmaceuticals announces board meeting date
 ( Corporate News - 13-May-25   15:58 )
  Ichnos Glenmark Innovation receives USFDA fast track designation for ISB 2001
 ( Corporate News - 05-May-25   19:16 )
Other Stories
  ZEN Technologies ends higher after receiving patent for long-pass optical filter
  30-Jun-25   18:44
  Torrent Pharma gains after inking pact to acquire majority stake in JB Chemicals & Pharma
  30-Jun-25   16:02
  Suditi Industries jumps 17% in seven days
  30-Jun-25   15:23
  J B Chemicals & Pharmaceuticals Ltd leads losers in 'A' group
  30-Jun-25   15:00
  Aimtron Electronics gains on inking Rs 98-crore ODM contract with US Firm
  30-Jun-25   14:52
  Sigachi Industries Ltd leads losers in 'B' group
  30-Jun-25   14:45
  Sigachi Industries drops after deadly explosion at Telangana facility
  30-Jun-25   14:32
  Volumes soar at Alembic Pharmaceuticals Ltd counter
  30-Jun-25   14:30
  HEC Infra secures Rs 3-cr work order from Ahmedabad Municipal Corporation
  30-Jun-25   14:26
  Jindal Steel commissions first galvanizing line at Angul Complex
  30-Jun-25   13:40
Back Top